ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 671425 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 671425; 2) Community: the network communities that were significantly associated with the response to NSC 671425; 3) Molecule: the relationships between components within communities and NSC 671425; 4) MDR: the compounds that were significantly associated with the NSC 671425.

NSC Compound Enrichment Correlation
NSC 707148 Card-20(22)-enolide, 3-[(6-deoxy-3-O-methyl-.beta.-D-galacto pyranosyl)oxy]-14-hydroxy-, (3.beta.,5.beta)- (9CI) 0.00311751113090891 0.29241401
NSC 752330 6-(2-(propan-2-ylidene)hydrazinyl)-9H-purine-9-beta-D-riboside 0.00311751113090891 0.31138399
NSC 629155 Null 0.00311751113090895 0.31348417
NSC 642071 Null 0.00314218974141796 0.1552683
NSC 694610 2,3-Dihydro-2,3-dihydroxy-brefeldin A 0.00314218974141796 -0.24792664
NSC 702655 Null 0.00314218974141796 0.45723808
NSC 176328 Ellipticine, 6-(3-aminopropyl)-, dihydrochloride 0.00352002370824895 0.27423053
NSC 660841 Null 0.00352002370824895 0.12800047
NSC 135687 5.beta.-Bufa-20,22-dienolide, 14,15.beta.-epoxy-3.beta.,5-dihydroxy-, 3-acetate (8CI) 0.00407837248037199 0.12409574
NSC 3077 s-Triazine, 4,6-diamino-1-(3,4-dichlorophenyl)-1,2-dihydro-2,2-dimethyl-, monohydrochloride (8CI) 0.00407837248037199 0.35232682
Total:38  Current:2    [First] [Prev] [Next] [Last]